logo
Hospital employee with Tourette syndrome says he was fired for ‘making faces' at boss

Hospital employee with Tourette syndrome says he was fired for ‘making faces' at boss

Yahoo11-04-2025

A hospital employee with Tourette syndrome got fired after just a week on the job when the head of HR allegedly became offended that the man — whose persistent tics, such as squinting, grimacing, and eye-blinking are totally involuntary — was 'making faces' at him.
In a federal civil rights lawsuit filed Friday and obtained first by The Independent, former project manager Adam Thompson accuses the White Plains Hospital Medical Center of violating the Americans with Disabilities Act by terminating him over a physical condition he cannot control.
The suit says Thompson disclosed his condition to hospital officials during the interview process and even provided a letter from his doctor that 'unequivocally' confirmed his fitness for duty.
Still, it contends, the VP of human resources mistook Thompson's spontaneous facial movements as 'confrontational' and called for his immediate termination.
In an email, White Plains Hospital's senior director of communications, Michael Gelormino, said, 'It is our policy not to comment on pending litigation.'
Thompson began working at White Plains Hospital on October 28, 2024 as a senior 'MEP' project manager, responsible for overseeing all mechanical, electrical, and plumbing systems throughout the facility, according to the complaint filed with his lawsuit.
His previous experience as an MEP manager, coordinator, and superintendent meant he'd easily be able to ensure all new construction met design specifications, safety codes, and deadlines, the complaint states.
Before he took the job, Thompson informed his supervisor-to-be that he suffers from Tourette syndrome as well as ADHD, but takes medication to control both and neither interfere at all with his ability to work, the complaint continues, adding that Thompson's personal physician confirmed as much in writing.
It says this 'proactive approach' met with 'positive feedback' from higher-ups, who recognized Thompson's 'competence and commitment.'
'However,' the complaint goes on, Thompson's 'situation took a troubling turn on November 4, 2024, during a mandatory New Hire Orientation.'
While at the orientation, Thompson briefly texted with his wife about 'urgent' childcare arrangements, according to the complaint.
'He was then abruptly confronted by… the Assistant Vice President of Human Resources, demanding that [he] put his phone away because he was 'disrespecting' the speakers,' the complaint states.
It says Thompson 'immediately complied,' offered an apology, and explained why he had been using the phone. But, the complaint alleges, the assistant VP of HR was unmoved, and instructed Thompson to leave the orientation.
During his interaction with the assistant VP of HR, Thompson 'exhibited typical symptoms' of Tourette syndrome, which the complaint describes as 'eye blinking, squinting, facial grimacing, twitching, and mouth movements.'
'All of these were symptoms out of [Thompson's] control,' the complaint states. 'Immediately after the orientation ended, [Thompson] met with [the assistant VP of HR] to apologize again and reiterated the circumstances, seeking to resolve the misunderstanding amicably. [The assistant VP] assured [Thompson] that the matter was resolved.'
Thompson then returned to the orientation, where, to his 'utter shock,' his supervisor told him that the assistant VP of HR was escalating the issue to his own bosses, according to the complaint.
The next day, Thompson met with the director of HR, who said his assistant VP 'remained upset,' and that the hospital's senior leadership was now involved, the complaint says.
The assistant VP had portrayed Thompson as 'confrontational,' and claimed he had been 'making faces' at him, the complaint states. But the faces were 'a direct result of' Thompson's Tourette syndrome, something he had 'openly disclosed' to the hospital, according to the complaint.
'On November 6, 2024, just two days after the incident… White Plains Hospital terminated [Thompson] from employment because he was allegedly 'confrontational' and 'making faces' at [the assistant VP of HR], with no further explanation provided,' the complaint says.
In recent years, numerous famous names have revealed their own Tourette syndrome diagnoses, including singer Billie Eilish, boxing champion Tevin Farmer, and comedian Dan Aykroyd. Most Tourette symptoms manifest themselves as Thompson's; very few people with Tourette syndrome blurt out curse words and swear uncontrollably.
Thompson is seeking damages to be determined by a jury, including compensation for mental anguish, emotional distress, humiliation, embarrassment, anxiety, and loss of self-esteem, self-confidence and personal dignity, plus reinstatement to his position at White Plains Hospital.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tourette Syndrome: A Look at Today's Best Treatments
Tourette Syndrome: A Look at Today's Best Treatments

Los Angeles Times

time5 hours ago

  • Los Angeles Times

Tourette Syndrome: A Look at Today's Best Treatments

Tourette syndrome (TS) is more than just a childhood phase of twitching or making sounds—it's a chronic neurodevelopmental condition that can disrupt daily functioning and emotional well-being. Characterized by both motor and vocal tics that begin before age 18 and last for more than a year, Tourette's often brings along other challenges like ADHD, obsessive-compulsive disorder (OCD), and anxiety. While some kids see symptoms lessen as they age, others need long-term, individualized treatment plans to manage both the tics and associated psychiatric conditions. Tourette syndrome is diagnosed when an individual has at least two motor tics and one vocal tic for more than 12 months, with onset before age 18 [1]. These tics are sudden, repetitive, and involuntary—for example, blinking, throat clearing, or shoulder shrugging. A helpful diagnostic clue is that people with TS can often suppress their tics briefly, unlike those with habit cough or psychogenic cough [1]. Differentiating TS from other movement or psychiatric disorders is key, especially since tics can wax and wane in intensity. That fluctuation, combined with the ability to voluntarily hold back tics for short periods, helps set Tourette's apart from conditions like dystonia or chorea. Behavioral therapy is the foundation of TS treatment, and CBIT is the gold standard. This structured approach combines habit reversal training with relaxation techniques and functional intervention strategies. CBIT helps individuals recognize premonitory urges—the sensations that precede tics—and teaches them to respond with competing behaviors that prevent the tic. CBIT has been shown to be effective across different delivery formats. A 2024 review found it worked in both in-person and telehealth settings—even when ADHD or OCD were present [4]. In fact, recent studies show that tele-CBIT sessions are almost as effective as in-office visits [5], making it a convenient option for families with busy schedules or living far from specialists. Medications like clonidine and guanfacine are often used for kids with mild to moderate tics—especially when ADHD is also present. These medications work on the brain's norepinephrine pathways to reduce hyperactivity and impulsivity which in turn can reduce tic severity. Their appeal is their safety profile. Compared to antipsychotics, alpha-2 agonists are less likely to cause serious side effects, making them a good starting point for young patients [2] [3]. When behavioral therapy and alpha-agonists don't work, antipsychotic medications may be added. These drugs target dopamine pathways—known to be involved in tic generation—but come with trade-offs. Aripiprazole and risperidone are commonly prescribed because they are better tolerated than older drugs like haloperidol. Meanwhile pimozide, a dopamine receptor blocker, has shown better outcomes than haloperidol in clinical trials [1]. For individuals with focal tics—like persistent eye blinking or neck movements—botulinum toxin injections can provide targeted relief by weakening overactive muscles [6]. Despite their effectiveness, antipsychotics require close monitoring. Side effects like sedation, weight gain, and movement disorders (e.g., tardive dyskinesia) can emerge especially with long-term use. Clinicians must weigh the benefits of symptom relief against the risk of side effects and adjust treatment accordingly [3]. For the small percentage of individuals with treatment-refractory TS, Deep Brain Stimulation (DBS) may be considered. DBS involves surgically implanting electrodes into specific brain regions to modulate abnormal activity. While still relatively rare and not standard care, DBS has shown promising results in reducing severe tics in select patients [6]. Beyond medical interventions, holistic care is key. Support groups, patient education and school-based accommodations—like extended test times or breaks during class—can make a big difference in a child's social and academic success. TS isn't just about the tics—it's about the whole person. Comorbidities like OCD, ADHD, and anxiety often impact daily life more than the tics themselves. So treatment plans must be individualized and medication choices should consider these overlapping conditions [2]. Clinicians must also distinguish tics from other movement disorders. Features like premonitory urges, voluntary suppression and the episodic nature of tics can help differentiate TS from other hyperkinetic disorders [1]. Tourette syndrome may be lifelong but it doesn't have to be life defining. With the right combination of behavioral therapy, medication, support and education most people can manage their symptoms and live well. As research advances—especially in digital therapy delivery and neuromodulation—there's more hope for more personalized, accessible and effective treatments for people with TS. [1] Irwin, R. S., Glomb, W. B., & Chang, A. B. (2006). Habit cough, tic cough, and psychogenic cough in adult and pediatric populations: ACCP evidence-based clinical practice guidelines. Chest, 129(1 Suppl), 174S–179S. [2] Egolf, A., & Coffey, B. J. (2014). Current pharmacotherapeutic approaches for the treatment of Tourette syndrome. Drugs of today (Barcelona, Spain : 1998), 50(2), 159–179. [3] Whittington, C., Pennant, M., Kendall, T., Glazebrook, C., Trayner, P., Groom, M., Hedderly, T., Heyman, I., Jackson, G., Jackson, S., Murphy, T., Rickards, H., Robertson, M., Stern, J., & Hollis, C. (2016). Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review. Journal of child psychology and psychiatry, and allied disciplines, 57(9), 988–1004. [4] Kohler, K., Rosen, N., & Piacentini, J. (2025). Description, Implementation, and Efficacy of the Comprehensive Behavioral Intervention for Tics as First-Line Treatment for Tourette and Other Tic Disorders. Journal of child and adolescent psychopharmacology, 35(3), 126–134. [5] Morand-Beaulieu, S., Szejko, N., Fletcher, J., & Pringsheim, T. (2024). Behavioural Therapy for tic disorders: a comprehensive review of the literature. Expert review of neurotherapeutics, 24(12), 1181–1191. [6] Billnitzer, A., & Jankovic, J. (2020). Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 17(4), 1681–1693.

Strattera vs Adderall: Which Works Faster for ADHD?
Strattera vs Adderall: Which Works Faster for ADHD?

Time Business News

time7 hours ago

  • Time Business News

Strattera vs Adderall: Which Works Faster for ADHD?

When it comes to treating ADHD (Attention Deficit Hyperactivity Disorder), both Strattera and Adderall are commonly prescribed medications. But a question many people ask is: Which one works faster? While both drugs can be effective in managing ADHD symptoms, they work in very different ways—and their speed of effectiveness reflects that. In this article, we'll break down how quickly strattera vs adderall start working, what affects their performance, and which might be a better choice depending on your needs. When considering treatment for anxiety or depression, selecting the right medication is crucial. Both medications have proven effective, but individual response may vary based on body chemistry and side effects. In the debate of Lexapro vs Zoloft, Lexapro is often praised for its smoother onset and fewer initial side effects, while Zoloft may be preferred for treating a wider range of conditions, including PTSD and OCD. Consulting a healthcare professional can help tailor the right approach, as factors like medical history and lifestyle play an essential role in determining the most suitable antidepressant. Before diving into how fast each medication works, it's important to understand what each drug is and how it functions: Adderall is a stimulant medication made up of amphetamine salts. It increases the levels of dopamine and norepinephrine in the brain—neurotransmitters associated with attention and focus. Adderall comes in two forms: immediate-release (IR) and extended-release (XR). Strattera (atomoxetine), on the other hand, is a non-stimulant medication. It works by selectively inhibiting the reuptake of norepinephrine, a different mechanism that takes more time to affect brain chemistry compared to stimulants. If you're looking for immediate symptom relief, Adderall is the faster option—hands down. Most people begin to feel its effects within 30 to 60 minutes after taking a dose. The immediate-release version typically lasts about 4–6 hours, while the extended-release form can last 10–12 hours. This makes Adderall an ideal choice for individuals who need quick and predictable symptom control, such as students or professionals who need to focus at specific times of day. Strattera doesn't work right away. In fact, it can take 2 to 4 weeks before noticeable improvements in focus or behavior occur, and up to 6–8 weeks for full benefits to kick in. This delay can be frustrating for individuals hoping for a rapid change. However, Strattera has its own advantages—it provides 24-hour coverage, and since it's not a stimulant, it may be better suited for those with coexisting anxiety, substance abuse history, or sleep issues. The faster effect of Adderall comes from how it directly boosts dopamine and norepinephrine levels almost immediately after ingestion. This sharp increase helps improve focus, reduce impulsivity, and calm hyperactivity in a short time frame. Strattera, on the other hand, gradually increases norepinephrine by preventing its reabsorption in the brain. This slow build-up is why it takes longer to feel the effects. However, this gradual adjustment can also lead to fewer emotional crashes or 'come-down' periods that some Adderall users experience. The speed of relief isn't the only factor to consider when choosing between Strattera and Adderall. Each has its own side effect profile: Adderall side effects can include insomnia, appetite suppression, jitteriness, increased heart rate, and the risk of dependence or misuse. Strattera may cause drowsiness, nausea, dry mouth, or mood swings—though it doesn't carry the same risk of addiction. People with coexisting anxiety or a history of substance misuse often tolerate Strattera better, even if it's slower to act. In contrast, someone who needs rapid symptom control during work or school hours might lean toward Adderall despite the side effect risks. Short-Term Goals: If the immediate goal is to improve focus for a test, meeting, or daily function, Adderall offers clear benefits thanks to its fast-acting nature. Long-Term Stability: For individuals looking for consistent, around-the-clock symptom control without the highs and lows of stimulant medication, Strattera may be the better fit—even though you'll need to be patient with the results. In some cases, doctors may even prescribe both medications at different times of day or for different symptom profiles. But this is done under close medical supervision. Choosing between Strattera and Adderall depends on your individual needs, health history, and treatment goals. Here are some questions to consider: Do you need fast results? Do you have a history of anxiety or substance abuse? Are you okay with taking a medication daily and waiting several weeks to feel the full effect? Do you need 24-hour symptom control? Always discuss these questions with your healthcare provider. They can help you weigh the benefits and drawbacks of each medication based on your personal circumstances. So, which works faster for ADHD—Strattera or Adderall? The clear winner in terms of speed is Adderall. It can start working in less than an hour and provide sharp symptom control for several hours. However, that quick relief comes with a higher potential for side effects and dependency. Strattera may take weeks to kick in, but for the right individual, it can offer consistent, all-day symptom relief without the crash or addiction risks associated with stimulants. Both medications have their place in ADHD treatment. The best choice isn't just about speed—it's about what works best for you in the long run. TIME BUSINESS NEWS

Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course
Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course

Yahoo

time8 hours ago

  • Yahoo

Excellent Brain Ltd. Announces Joint Venture with MasNeuros to Launch Spanish Neurofeedback Trainers Course

Excellent Brain Ltd. Expands Global Reach with Spanish Neurofeedback Course Natanya, Israel , June 18, 2025 (GLOBE NEWSWIRE) -- Excellent Brain Ltd., an innovative Israeli start-up renowned for its advanced neurofeedback solutions, has announced a strategic joint venture with MasNeuros, a leading Spanish organization. This collaboration aims to deliver the Excellent Brain's Trainers Course in Spanish, focusing on Neurofeedback for ADHD, utilizing the cutting-edge Excellent Brain Neurofeedback Brain - Neurofeedback for ADHDThe first course, successfully completed in May 2025, marks a significant milestone in making neurofeedback training accessible to Spanish-speaking clinics. This initiative is set to empower healthcare professionals across Spanish-speaking countries, providing them with the most effective tools for managing ADHD in clinical settings. Ofer A. Lidsky, CEO and founder of Excellent Brain Ltd., expressed his enthusiasm for the collaboration, stating, "Partnering with MasNeuros allows us to extend our innovative neurofeedback training to a broader audience. This joint venture is a testament to our commitment to enhancing cognitive health and providing accessible solutions for ADHD management worldwide." The Excellent Brain Neurofeedback platform is celebrated for its ability to leverage EEG signal processing to enhance brain function. By offering training programs that improve various cognitive aspects, particularly for individuals with ADHD, the platform stands as a beacon of innovation in mental wellness and cognitive enhancement. This joint venture not only broadens the reach of Excellent Brain's pioneering technology but also reinforces its position as a leader in the field of neurofeedback. By collaborating with MasNeuros, Excellent Brain Ltd. is poised to make a significant impact on the mental health landscape in Spanish-speaking regions. The completion of the first course signifies the beginning of a new era in neurofeedback training, where language is no longer a barrier to accessing world-class cognitive enhancement tools. Clinics in Spanish-speaking countries can now integrate these advanced solutions into their practices, offering patients the benefits of cutting-edge ADHD management Training for improving ADHD symptomsAbout Excellent Brain Ltd. Excellent Brain Ltd., founded in 2015 by entrepreneur Ofer A. Lidsky, is an innovative Israeli start-up specializing in advanced neurofeedback solutions. The company's cutting-edge platform leverages EEG signal processing to enhance brain function, offering accessible training programs aimed at improving various cognitive aspects, particularly for individuals with ADHD. Excellent Brain's technology enables users to engage in neurofeedback and virtual reality-based training, promoting mental wellness and cognitive enhancement. Press inquiries Excellent Brain Ltd. Ofer Lidsky ofer@ A video accompanying this announcement is available at in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store